We need an army of supporters in the battle against pediatric AML. As we discover and understand more about the various genetic mutations in pediatric AML, we are better able to identify targets. Immunotherapy goes after these targets- resulting in treatment that is far more effective and less toxic.
Pediatric AML is tremendously underfunded and undereseached, leaving young children with few options. Treatment protocols are tailored to adults and fail to accurately address the unique subtypes of pediatric cancer. Please help us spread awareness and raise funding. We can do better. We have to do better.
There are two ways to keep up to date on Project Stella. You can subscribe to the newsletter link below (your email address will never be shared with any marketing group), or by visiting this website.
We’re making progress but we need help to make it to the finish line.
Oct 13, 2021 Newsletter—> https://mailchi.mp/projectstella/project-stella-news-letter-4194758
May 11, 2021 Newsletter—> https://mailchi.mp/projectstella/project-stella-news-letter-4118314